3004.90.92.02 - Antivirals 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This HTS category, 3004.90.92.02, specifically covers antiviral medicaments. These are pharmaceutical preparations designed for the therapeutic or prophylactic treatment of viral infections. They are presented in measured doses or in retail packings, distinguishing them from bulk pharmaceutical ingredients or materials not yet formulated for direct use.
The defining characteristic of this category is its specificity to combating viruses, differentiating it from sibling categories such as antifungals (which target fungal infections) and antiprotozoals (which address infections caused by protozoa). While all fall under the broader umbrella of anti-infective medicaments, the specific pathogen targeted is the key differentiator. Sulfonamides, another sibling, are a distinct class of antibacterial agents.
As a leaf node, this category does not contain further subdivisions. Therefore, classification under 3004.90.92.02 relies on accurately identifying the product's intended use as an antiviral agent, its formulation into measured doses or retail packs, and its exclusion from other medicament headings within Chapter 30. Examples would include medications formulated to treat influenza, HIV, herpes, or hepatitis C.